Chimerix (CMRX) – Mergers and Acquisitions
-
Chimerix (CMRX) and Emergent BioSolutions (EBS) Disclose Expiration of HSR Waiting Period for Acquisition of Rights to Brincidofovir
-
Emergent BioSolutions (EBS) to Acquire Chimerix's (CMRX) Exclusive Worldwide Rights to TEMBEXA for up to $325M
-
-
Back to CMRX Stock Lookup